First Scientific and Organizational Meeting
March 20, 2015 | San Francisco, CA

REGISTER NOW

AGENDA

Association for Business Development
and Marketing in Dermatology

 

Friday, March 20th
	9:00 am	Registration Check-in and Breakfast in the Intersection Room
	10:00-10:15 am	Welcome and Opening Remarks, followed by “2013-2014; Year in Review,” Speakers: Sarah Koch, MD, MBA, Casey Watkins, MD, Wake Forest Baptist Health
	10:15-11:45 am	Industry Showcase: 9 medical dermatology companies will present for 10 minutes each. Participants will talk about their products and business development strategies. Speakers include: Wade Hull, Vice President. Research & Development, Nuvo Research, on innovative topical drug delivery technologies for dermatology and pain management applications; Craig Dees, PhD, Chief Executive Officer, Provectus Biopharmaceuticals, Inc., on PH-10, an investigational new drug for psoriasis and atopic dermatitis; Paul Castella, PhD, MBA, CEO of Santalis Pharmaceuticals, on development of OTC products and Rx drug candidates to treat acne, eczema, psoriasis and topical viral diseases based on the pharmacologic properties of East Indian Sandalwood Oil (EISO), sourced under an exclusive supply agreement; Dov Tamarkin, PhD, CEO, Foamix Pharmaceuticals, on innovative foam technologies for topical drug delivery, with emphasis on clinical-stage FMX101, a 4% minocycline foam for treatment of moderate-to-severe acne; Erik Wiberg, Senior Vice President, Anacor Pharmaceuticals, on AN2728, nonsteroidal topical in phase 3 trials for treatment of mild-to-moderate atopic dermatitis; and Rick Coulon, President and CEO, Accuitis, on a first in class proteasome inhibitor (ACU-101) for treatment of rosacea and other dermatology conditions. Moderator: Jim Schutz, Chief Executive Officer, Oculus Innovative Sciences.
	11:45 am-12:00 pm	“The Dermatology Market – A Wall Street Perspective” Speaker: David Steinberg, Managing Director, Equity Research, Jefferies
	12:00-12:30 pm	Luncheon Luncheon Keynote: “A View From the Top - Innovation in Dermatology.” Speakers: Leon Kircik, MD, Associate Clinical Professor of Dermatology, Indiana University School of Medicine, Mount Sinai Medical Center. DermResearch PLLC, Louisville, KY; and Jeffrey Weinberg, MD, Attending Physician, Department of Dermatology, Mount Sinai St. Luke’s Roosevelt, and Mount Sinai Beth Israel, New York, NY
	12:30-1:30 pm	Industry Showcase: innovative aesthetic dermatology companies will present for 15 minutes each. Speakers include: Eric McDonald, Director of Sales, USA, Telomerase Activation Sciences, on TA-65MD nutritional supplement and TA-65 for skin; Vincent Gotz, Senior Vice President, MDRejuvena, Inc, will introduce this new company in the physician- dispensed channel and their product offerings; Robert M. Levy, MD, Director of Clinical Development, Primus Pharmaceuticals, Inc. will discuss Vasculera which treats symptomatic venous insufficiency, edema, spider veins, varicose veins, hemorrhoids, stasis dermatitis, venous ulcer &other conditions; Robert Norman, DO, MPH, on StatClean, 50+ skin care, and mobile radiation services; and Mark Tager, MD, Change Well Inc., on Emerging Opportunities in Aesthetics. Moderator: Jeff Wasserstein, Managing Director, Greenhill & Co.
	1:30-1:45 pm	Zoe Diana Draelos, MD, will speak on the Future of Dermatology on problems associated with the skin, hair, and nails.
	1:45-2:00 pm	Frank Watanabe, Vice President, Strategy and Corporate Development, Kythera Biopharmaceuticals, will speak on ATX-101, an injectable under FDA review for U.S. approval to reduce submental fat (double chin).
	2:00-2:30 pm	“Developing an Effective Dialogue with the FDA.” Panel members include Jim Lee, Global Head, Clinical Development, Stiefel R&D, a GSK company, and Robert Reardon, PhD, Executive Vice President and COO, TKL Research, Inc.
	2:30-3:15 pm	“Physician Entrepreneurship in Dermatology:  Innovation and Invention”  Panel members include: Robert Norman, DO, MPH; Rex Bright, President and CEO, Seabright Associates, and cofounder, SkinMedica, on Keys to Success in Aesthetics: Transitioning from Drugs to Aesthetics; and Mark Tager, MD, Change Well Inc., on what it takes to be a successful physician entrepreneur. Moderator: Clay J. Cockerall, MD
	3:15-3:45 pm	Afternoon Refreshment and Networking Break
	3:45-4:00 pm	Richard D. Katz, MD, Chief Business and Financial Officer, Viamet Pharmaceuticals, Inc., will speak about VT-1161, a novel oral antifungal in Phase 2B clinical development for the treatment of onychomycosis
	4:00-5:30 pm	Networking Reception